Fentanyl Citrate Injection · #2 of 35 active shortages by FDA posting duration
Brand: FENTANYL CITRATE
FDA lists Fentanyl Citrate Injection as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Available
Fentanyl Citrate Injection: Active Shortage
Available 19 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Fentanyl Citrate Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28)
- Package NDC
- 0409-9094-28
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Jan 1, 2012
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Analgesia/Addiction, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
fentanyl
Side effects, interactions, warnings & more
Nearby, Other Fentanyl Shortage Records
Fentanyl Citrate Injection
Fresenius Kabi USA, LLC
Injection
Fentanyl Citrate Injection
Fresenius Kabi USA, LLC
Injection
Fentanyl Citrate Injection
Hospira, Inc., a Pfizer Company
Injection
Fentanyl Citrate Injection
Hospira, Inc., a Pfizer Company
Injection
Fentanyl Citrate Injection
Hospira, Inc., a Pfizer Company
Injection
Fentanyl Citrate Injection
Hospira, Inc., a Pfizer Company
Injection